Medical facilities all across the nation send data about patients who have been diagnosed with cancer. These cases are logged with the cancer registry. Most of the cancer registry data comes from hospitals, where trained cancer registrars collate information from patient medical records and transfer them to the central cancer registry as standardized codes. Among the data collected are incidence, demographic, and clinical data.
This data is recorded by the CDC’s National Program of Cancer Registries (NPCR) and the National Cancer Institute’s (NCI) Surveillance, Epidemiology and End Results (SEER) Program. The information submitted to the CDC is de-identified (no personal data about individual patients) and is used to:
- Monitor cancer trends over time.
- Show cancer patterns in various populations and identify high-risk groups.
- Guide planning and evaluation of cancer control programs.
- Help set priorities for allocating health resources.
- Advance clinical, epidemiologic, and health services research.
As part of the CDC’s efforts to fulfill Cancer Registries Amendment Act (1992), there have been many enhancements that we have been tracking, namely:
The Breast, Colon, and Prostate Cancer Data Quality and Patterns of Care Study that expands the registry data to include data from thousands of patient cases to define unique patterns of care patients received and the quality of treatment.
The Breast and Prostate Cancer Data Quality and Patterns of Care Study that produced data-supported patterns of care for cancer patients. The study was conducted in collaboration with seven registries that comprised more than 24,000 patients diagnosed with female breast or prostate cancer.
Simplifying the Process
Direct Difference consistently monitor this and other registries to broaden our abstraction process. Your task is to improve cancer treatment. Our job will be to provide you with the highest abstraction accuracy attainable.